Physostigmine is an alkaloid originally derived from the Calabar bean (Physostigma venenosum). Physostigmine is noted to act as a potent and reversible inhibitor of cholinesterase. Physostigmine is also reported to form a slowly degrading carbamylated enzyme complex with acetylcholinesterase (AChE). Physostigmine has been used as a positive control in a study investigating acetylcholinesterase inhibitors for potential antihelminthic drug targets. Additionally, as a parasympathomimetic compound, Physostigmine is reported to cross the blood-brain barrier.
1. Tamaddonfard, E. and Hamzeh-Gooshchi, N. 2010. Pharmacol Rep. 62: 858-863. PMID: 21098868
2. Valli, M., et al. 2011. Curr Med Chem. [Epub ahead of print]. PMID: 21728957
3. Kalogiannis, M., et al. 2011. PLoS ONE. 6: e18697. PMID: 21533254
See how others have used Physostigmine (CAS 57-47-6). Click on the entry to view the PubMed entry .
PMID: # 25269881 Lau, CG. et al. 2014. Mol. Reprod. Dev. 81: 994-1008.
PMID: # 31153601 J Chromatogr A. 458-466.
PMID: # 30557385 PLoS ONE. 13: e0209250.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2021 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.